Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rizatriptan-Naproxen in the Acute Treatment of Migraine
NCT04384367Phase 3Completed
- Sponsor
- Eurofarma
- Start
- Dec 2022
- Primary completion
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of rizatriptan, naproxen in migraine, sponsored by Eurofarma. Started Dec 2022; status: completed.
02
Drugs
rizatriptannaproxen
03
Conditions
migraine
Beyond the preview
Go deeper on NCT04384367.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04384367.